HK:3347 Hangzhou Tigermed Consulting Ltd H

Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization in China and internationally. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting; clinical services in the areas of medical science, early clinical development, late phase development, medical monitoring, project management, patient recruitment, and quality management system; and biometrics services covering data management, biostatistics, and statistical programming. It also provides integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital; medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, IVD, GMP certificate, EU MDR and IVDR preparation, and value added services; and post-marketing study, real world evidence, and vaccine clinical trial services. The company was founded in 2004 and is based in Hangzhou, China.

78.20 HKD
As of 08/12/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  
Index country:  China
Country of incorporation:  China
IPO date:  08/07/2020
Stock exchange:    Hong Kong Exchange
Exchange country:   Hong Kong
Market cap:   0 HKD
Current dividend yield:   0.00%
Sedol:      BMZC7F8

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy